Maripau Wealth Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Buy
1,132
+162
+17% +$68.1K 0.19% 92
2026
Q1
$366K Buy
970
+50
+5% +$21.4K 0.16% 111
2025
Q4
$393K Buy
920
+73
+9% +$31.8K 0.18% 106
2025
Q3
$379K Sell
847
-210
-20% -$95.1K 0.19% 98
2025
Q2
$524K Buy
1,057
+138
+15% +$78.6K 0.26% 83
2025
Q1
$566K Buy
919
+243
+36% +$138K 0.32% 71
2024
Q4
$358K Buy
+676
New +$381K 0.21% 93

Other funds holding CHE

Maripau Wealth Management's CHE Position: Q2 2026 in Review

Maripau Wealth Management increased its Chemed (CHE) stake by 17% in Q2 2026, buying an estimated $68.1K and bringing the position to 1,132 shares worth $530K. The position accounts for 0.19% of the portfolio, ranked #92.

Maripau Wealth Management first reported a position in CHE in Q4 2024 and has held it in 7 quarters since. The position peaked at $566K in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Maripau Wealth Management held 1,132 shares of Chemed worth $530K as of Q2 2026.
  • Maripau Wealth Management bought 162 Chemed shares in Q2 2026, an estimated $68.1K.
  • Chemed made up 0.19% of Maripau Wealth Management's portfolio in Q2 2026, its #92 holding.
  • Maripau Wealth Management first reported a position in Chemed in Q4 2024 and has held it in 7 quarters since.
  • Maripau Wealth Management's Chemed position peaked at $566K in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Maripau Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.